New research reveals that patients who stop using popular slimming jabs like Wegovy and Mounjaro may regain reduced body mass far faster than those who halt traditional diet and exercise regimens.
Findings released in a prominent medical journal demonstrates that while overweight individuals can lose substantial amounts of their total mass while on the medication, the weight returns at an estimated rate of nearly a kilo each month after stopping.
"People purchasing these drugs should be informed of the risk of rapid rebound weight gain when the treatment concludes," stated expert Dr. Susan Jebb.
That rate of regain implies a return to pre-treatment weight within about one and a half years.
Weighing Approaches
The study, which examined 37 of studies involving over 9,000 of patients, contrasted the results of GLP-1 agonists with conventional dieting.
Scientists point out that people who lose weight through diet and exercise typically have a slower weight regain—approximately 100 grams monthly—after stopping.
The Reason for the Rapid Rebound
Doctors believe the mode of action of the drugs accounts for the amplified weight return.
The injections imitate a body's own chemical called GLP-1, which controls feelings of fullness.
"Artificially providing the hormone concentrations far above than normal may cause the system to generate a reduced amount of its endogenous hormone, and may also diminish sensitivity to its effects," explained Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this medication means hunger is uncontrolled, making excessive eating far more likely."
A Chronic Condition?
The NHS suggest the injections for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes.
Many experts argue that, due to the high risk of relapse, the treatment should be considered life-long.
This perspective is supported by pharmaceutical companies, who say that the findings "highlight the long-term nature of obesity," similar to managing conditions like hypertension.
User Testimonies
People who have discontinued the medication explain a powerful return of hunger.
"I experienced a switch flipping and you're instantly ravenous," said a patient.
This difficulty is exacerbated if individuals have not adopted lasting lifestyle or habit modifications during treatment.
Significant Interest
Recent estimates show that millions of people in the UK have tried weight-loss jabs in the past year, with interest continuing to grow.
- Adoption is more common among women than men.
- The middle-aged demographic shows the greatest level of interest.
- A large proportion obtain the drugs through private prescriptions rather than public health services.
In conclusion, experts caution that while GLP-1 drugs are potent tools for shedding pounds, they are not a standalone solution and maintained weight loss hinges on integrated lifestyle management.
